Isabella Feierberg
Isabella Feierberg
Jnana Therapeutics
No verified email
Cited by
Cited by
Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems
J Marelius, K Kolmodin, I Feierberg, J ┼qvist
Journal of Molecular Graphics and Modelling 16 (4), 213-225, 1998
Free energy calculations and ligand binding
BO Brandsdal, F Ísterberg, M Alml÷f, I Feierberg, VB Luzhkov, J ┼qvist
Advances in protein chemistry 66, 123-158, 2003
Potent Inhibitors of the Plasmodium falciparum Enzymes Plasmepsin I and II Devoid of Cathepsin D Inhibitory Activity
K Ersmark, I Feierberg, S Bjelic, E Hamelink, F Hackett, MJ Blackman, ...
Journal of medicinal chemistry 47 (1), 110-122, 2004
Computer simulation of primary kinetic isotope effects in the proposed rate-limiting step of the glyoxalase I catalyzed reaction
I Feierberg, V Luzhkov, J ┼qvist
Journal of Biological Chemistry 275 (30), 22657-22662, 2000
Computational modeling of enzymatic keto-enol isomerization reactions
I Feierberg, J ┼qvist
Theoretical Chemistry Accounts 108, 71-84, 2002
The catalytic power of ketosteroid isomerase investigated by computer simulation
I Feierberg, J ┼qvist
Biochemistry 41 (52), 15728-15735, 2002
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions
K Ersmark, I Feierberg, S Bjelic, J HultÚn, B Samuelsson, J ┼qvist, ...
Bioorganic & medicinal chemistry 11 (17), 3723-3733, 2003
Energetics of the proposed rate‐determining step of the glyoxalase I reaction
I Feierberg, AD Cameron, J ┼qvist
FEBS letters 453 (1-2), 90-94, 1999
Comparative binding energy analysis for binding affinity and target selectivity prediction.
WRC Henrich S, Feierberg I, Wang T, Blomberg N
Proteins 78 (1), 135-53, 2010
Identification of Compounds That Interfere with High‐Throughput Screening Assay Technologies
L David, J Walsh, N Sturm, I Feierberg, JWM Nissink, H Chen, J Bajorath, ...
ChemMedChem 14 (20), 1795-1802, 2019
A small-molecule PI3Kα activator for cardioprotection and neuroregeneration
GQ Gong, B Bilanges, B Allsop, GR Masson, V Roberton, T Askwith, ...
Nature 618 (7963), 159-168, 2023
Public-private partnerships: compound and data sharing in drug discovery and development
AM Davis, O Engkvist, RJ Fairclough, I Feierberg, A Freeman, P Iyer
SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (5), 604-619, 2021
On the relationship between molecular hit rates in high-throughput screening and molecular descriptors
M Hansson, J Pemberton, O Engkvist, I Feierberg, L Brive, P Jarvis, ...
Journal of Biomolecular Screening 19 (5), 727-737, 2014
Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS)
F Edfeldt, J Evenńs, M Lepist÷, A Ward, J Petersen, L Wissler, M Rohman, ...
Bioorganic & medicinal chemistry letters 25 (12), 2496-2500, 2015
Computational Studies of Enzymatic Enolization Reactions and Inhibitor Binding to a Malarial Protease
I Feierberg
Acta Universitatis Upsaliensis, 2003
Hit series selection in noisy HTS data: clustering techniques, statistical tests and data visualisations
C MŘller, D Ormsby, I Feierberg, O Engkvist, C Tyrchan, MJ Hartshorn
Journal of Cheminformatics 6, 1-1, 2014
New potent inhibitors of the malarial aspartyl proteases plasmepsin I and II devoid of cathepsin D inhibitory activity
KE Ersmark, I Feierberg, S Bjelic, E Hamerlink, J Hulten, B Samuelsson, ...
Correction: The Catalytic Power of Ketosteroid Isomerase Investigated by Computer Simulation
I Feierberg, J ┼qvist
Biochemistry 42, 2258, 2003
ENZYME CATALYSIS AND REGULATION-Computer simulation of primary kinetic isotope effects in the proposed rate-limiting step of the glyoxalase I catalyzed reaction
I Feierberg, V Luzhkov, J Aqvist
Journal of Biological Chemistry 275 (30), 22657-22662, 2000
The system can't perform the operation now. Try again later.
Articles 1–19